Skip to main content
OpenTrials

Clinical trial condition

Infections, Papillomavirus

Explore clinical trials studying Infections, Papillomavirus. Study availability and eligibility vary by location and protocol.

61 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Infections, Papillomavirus trial results

Completed

Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects

NCT00947115

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +22 more
Locations
  • GSK Investigational Site Munich, Bavaria, Germany
  • GSK Investigational Site Würzburg, Bavaria, Germany
  • GSK Investigational Site Berlin, Germany
  • GSK Investigational Site Bydgoszcz, Poland
View Trial Details
Completed

Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females

NCT01031069

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +23 more
Locations
  • GSK Investigational Site Porto Alegre, Rio Grande do Sul, Brazil
  • GSK Investigational Site Ribeirão Preto, São Paulo, Brazil
  • GSK Investigational Site Campinas, Brazil
  • GSK Investigational Site Rio de Janeiro, Brazil
View all 15 locations
View Trial Details
Completed

Evaluation of Immunogenicity and Safety of Two 2-dose Human Papillomavirus (HPV) Vaccine Schedules in 9-14 Year Old Girls

NCT01381575

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +22 more
Locations
  • GSK Investigational Site Coquitlam, British Columbia, Canada
  • GSK Investigational Site Halifax, Nova Scotia, Canada
  • GSK Investigational Site Greater Sudbury, Ontario, Canada
  • GSK Investigational Site Toronto, Ontario, Canada
View all 33 locations
View Trial Details
Completed

Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects.

NCT00877877

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +23 more
Locations
  • GSK Investigational Site Bogotá, Colombia
  • GSK Investigational Site Deggingen, Baden-Wurttemberg, Germany
  • GSK Investigational Site Ettenheim, Baden-Wurttemberg, Germany
  • GSK Investigational Site Kehl, Baden-Wurttemberg, Germany
View all 26 locations
View Trial Details
Completed

Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older

NCT00294047

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +23 more
Locations
  • GSK Investigational Site Fountain Valley, California, United States
  • GSK Investigational Site Aurora, Colorado, United States
  • GSK Investigational Site Golden, Colorado, United States
  • GSK Investigational Site Coral Gables, Florida, United States
View all 75 locations
View Trial Details
Completed

Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age

NCT00423046

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +23 more
Locations
  • GSK Investigational Site Chandler, Arizona, United States
  • GSK Investigational Site San Diego, California, United States
  • GSK Investigational Site San Francisco, California, United States
  • GSK Investigational Site Vista, California, United States
View all 40 locations
View Trial Details
Completed

Human Papillomavirus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Biologicals Novel HPV Vaccine

NCT00359619

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +12 more
Locations
  • GSK Investigational Site Denver, Colorado, United States
  • GSK Investigational Site Golden, Colorado, United States
  • GSK Investigational Site Salt Lake City, Utah, United States
  • GSK Investigational Site Salt Lake City, Utah, United States
View Trial Details

Related conditions